Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 1,034 | 1,012 | 1,001 | 1,461 | 1,248 |
| Cost of Goods | 440 | 410 | 510 | 740 | 680 |
| Gross Profit | 600 | 600 | 480 | 720 | 580 |
| Operating Expenses | 1,150 | 1,040 | 1,300 | 1,530 | 1,550 |
| Operating Income | -116 | -28 | -299 | -69 | -302 |
| Other Income | 26 | 8 | 19 | 39 | 52 |
| Pre-tax Income | -90 | -20 | -280 | -30 | -250 |
| Income Tax | -77 | -1 | -130 | -2 | -210 |
| Net Income Continuous | -15 | -19 | -148 | -35 | -40 |
| Net Income | $-15 | $-19 | $-148 | $-35 | $-40 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.05 | -0.01 | -0.01 |
| EBITDA(a) | $4 | $72 | $-199 | $31 | $-202 |